Perquietil en es it fr

Perquietil Brand names, Perquietil Analogs

Perquietil Brand Names Mixture

  • No information avaliable

Perquietil Chemical_Formula


Perquietil RX_link

No information avaliable

Perquietil fda sheet

Perquietil msds (material safety sheet)

Perquietil Synthesis Reference

No information avaliable

Perquietil Molecular Weight

309.469 g/mol

Perquietil Melting Point

< 25 oC

Perquietil H2O Solubility

Soluble as HCl salt

Perquietil State


Perquietil LogP


Perquietil Dosage Forms

Tablets (oral, 1 mg)

Perquietil Indication

Used for the symptomatic treatment of parkinsonism.

Perquietil Pharmacology

Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.

Perquietil Absorption

Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.

Perquietil side effects and Toxicity

Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.

Perquietil Patient Information

Perquietil Organisms Affected

Humans and other mammals